Lomustine

This classification denotes a nitrosourea compound with the molecular formula C9H16ClN3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7BRF0Z81KG, chemically known as 1-nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl- but more generally known as lomustine, which bears US NIH Compound Identifier 3950. European Medicines Agency schedules Lomustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08567MIG. The term LOMUSTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules lomustine in its Anatomical Therapeutic Chemical (ATC) Classification. LOMUSTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule lomustine under HS 29242190 and SITC 51473. As of Q4 2014, LOMUSTINE remains US FDA's Preferred Term for this commodity. Lomustine bears US NLM identifiers UMLS ID C0699181 and NCI Concept Code C617. SMILES: CLCCN(N=O)C(=O)NC1CCCCC1.